WHX 2026
Join Vermon at WHX 2026, in Dubai, UAE, from February 9 to February 12, North Hall 21, K.92.
Dubai, UAE
The Med-IPUT project, funded by the European Union’s Horizon Europe program and the Swiss State Secretariat for Education, Research and Innovation (SERI), is a groundbreaking initiative focused on developing advanced Med-IPUT ultrasound transducers. These innovative devices aim to improve ultrasound imaging and diagnostics.
By leveraging integrated photonic technologies, Med-IPUT seeks to develop a new generation of ultrasound transducers with unprecedented sensitivity, performance, and versatility.
Vermon is proud to be a key contributor to this project, bringing decades of expertise in ultrasound technology to the consortium.
Modern ultrasound imaging faces critical limitations, including sensitivity constraints, shallow penetration depths, and the need for high acoustic pressures. These barriers affect image quality, while regulatory compliance and market scalability add layers of complexity to the adoption of new technologies. Med-IPUT’s solution lies in pioneering Integrated Photonic Ultrasound Transducers (IPUTs).
These transducers are expected to be up to 100 times more sensitive than current ultrasound sensors, significantly improving image resolution and penetration depth.
The Med-IPUT partners develop several IPUT sensors, ultimately leading to two innovative demonstrators:
– A medical imaging probe for conventional ultrasound
– A probe for photoacoustic applications
Vermon leads the design of demonstrators that combine piezoelectric and photonic technologies. This includes the mechanical integration and assembly of prototypes, ensuring robust performance and reliability.
With its expertise in characterization protocols, Vermon develops and executes, in collaboration with TNO, detailed testing plans to evaluate the sensitivity, resolution, and operational stability of the prototypes.
Med-IPUT unites leading organizations in photonics, materials science, and medical imaging, including TNO (The Netherlands Organisation for Applied Scientific Research), VTT Technical Research Centre of Finland, Ligentec, and EIBIR (European Institute for Biomedical Imaging Research).
Med-IPUT aims to enhance medical imaging by providing more reliable and earlier diagnostics, reducing the need for invasive or costly imaging methods while improving patient health.
The project addresses key technical challenges and paves the way for improved diagnostic capabilities and patient outcomes.
WHX 2026
Join Vermon at WHX 2026, in Dubai, UAE, from February 9 to February 12, North Hall 21, K.92.
Dubai, UAE
Read More
EcoVadis Gold Medal 2025: Vermon Among the Top 5% of Rated Companies
Vermon has been awarded the EcoVadis Gold Medal 2025 for the second consecutive year, recognizing its strong commitment to Corporate Social Responsibility. This distinction places Vermon among the top 5% of companies worldwide, highlighting its continuous efforts in sustainability, ethics, and responsible business practices.
Read More
Vermon Wins the INPI Export Award 2025 for Innovation and Intellectual Property
Vermon has been awarded the INPI Export Award 2025, recognizing the strength of our intellectual property strategy and its role in supporting the international development of our high-performance ultrasound technologies. This distinction highlights Vermon’s contribution to French medical innovation and its global impact in the field of medical ultrasound and diagnostic imaging.
Read More
Multidisciplinary Group Awarded in France 2030 Plan to Develop Next-Generation Software-Based, Smart, and Frugal Ultrasound Imaging Devices
The POCUSI (Point of Care UltraSound for Screening & Intervention) consortium—bringing together E-Scopics, Vermon, IHU Strasbourg, and Inria—has been awarded funding under the France 2030 investment plan to develop a new generation of software-based, intelligent, and frugal ultrasound imaging devices.
With a total budget of €6.7 million over five years, the project aims to democratize point-of-care ultrasound, making advanced imaging accessible to non-expert operators throughout the patient care pathway. POCUSI focuses particularly on chronic liver diseases and metabolic disorders, enabling improved screening, monitoring, and image-guided interventions. By combining cutting-edge software, high-performance probes, clinical expertise, and data-driven simulation tools, POCUSI supports the emergence of a strategic and sustainable French digital ultrasound sector, strengthening France’s technological sovereignty in medical imaging.
Read More
RSNA 2025
Join Vermon at RSNA 2025 in Chicago, USA, from November 30 to December 4. Discover our latest ultrasound transducer innovations and meet our team in North Hall, Level 3 – Booth 8049.
CHICAGO, USA
Read More